RXi Pharmaceuticals Acquires MirImmune For Cancer Immunotherapy Prospects – Seeking Alpha
Seeking Alpha |
RXi Pharmaceuticals Acquires MirImmune For Cancer Immunotherapy Prospects
Seeking Alpha The deal brings two drug candidates and the potential to market RXi's platform to the significant cancer immunotherapy market. I'm positive on RXII's short- and medium-term prospects. Quick Take. Dermal scarring treatment company RXi Pharmaceuticals … |
